Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › District of Columbia › Washington
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in Washington, DC
4 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 2
- Site Number - 1630, Washington D.C.
- Site Number - 1601, Washington D.C.
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
RecruitingPhase 3
- Medstar Health Research Institute, Washington D.C.
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
RecruitingPhase 3
- MedStar Washington Hospital Center, Washington D.C.
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
RecruitingPhase 3
- Clinical Study Site, Washington D.C.
Chronic Inflammatory Demyelinating Polyradiculoneuropathy trials in other cities
- New York City, NY7 studies
- Houston, TX6 studies
- Miami, FL6 studies
- St. Louis, MO5 studies
- New Haven, CT5 studies
- Indio, CA5 studies
- Kansas City, KS5 studies
- Philadelphia, PA5 studies
- San Francisco, CA4 studies
- Birmingham, AL4 studies
- Tampa, FL4 studies
- Orlando, FL4 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.